Artificial selection for intrinsic aerobic endurance running capacity in rats

Functional Genomics Laboratory, Medical College of Ohio, Toledo, Ohio 43614-5804 Artificial selection for intrinsic aerobic endurance running capacity was started using genetically heterogeneous N:NIH stock of rats as a founder population ( n = 168). Selection for low and high capacity was based upo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physiological genomics 2001-02, Vol.5 (1), p.45-52
Hauptverfasser: KOCH, LAUREN GERARD, BRITTON, STEVEN L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Functional Genomics Laboratory, Medical College of Ohio, Toledo, Ohio 43614-5804 Artificial selection for intrinsic aerobic endurance running capacity was started using genetically heterogeneous N:NIH stock of rats as a founder population ( n = 168). Selection for low and high capacity was based upon distance run to exhaustion on a motorized treadmill using a velocity-ramped running protocol. The starting velocity was 10 m/min and was increased by 1 m/min every 2 min (slope was constant at 15°). At each generation, within-family selection was practiced using 13 families for both the low and high lines. A rotational breeding paradigm maintained the coefficient of inbreeding at less than 1% per generation. On average the founder population ran to exhaustion in 355 ± 11 m. Six generations of selection produced lines that differed in running capacity by 171%, with most of the change occurring in the high line. At generation 6 the low line ran 310 ± 8 m and the high line 839 ± 21 m at exhaustion. Selection for running capacity produced changes in body weight as a correlated trait. By generation 6 , the low-line females were 20% heavier than the high-line females, and the low-line males were 16% heavier than the high-line males. treadmill; breeding; models; gene; performance
ISSN:1094-8341
1531-2267
DOI:10.1152/physiolgenomics.2001.5.1.45